Resolution Therapeutics
1 known investors
Resolution develops a macrophage cell therapy to treat end-stage liver disease, aiming to reduce the need for liver transplantation and improve patient outcomes. The company focuses on regenerative medicine for inflammatory and fibrotic diseases.
Investors · 1
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Resolution Therapeutics do?
- Resolution develops a macrophage cell therapy to treat end-stage liver disease, aiming to reduce the need for liver transplantation and improve patient outcomes. The company focuses on regenerative medicine for inflammatory and fibrotic diseases.
- Who are Resolution Therapeutics's investors?
- Resolution Therapeutics's investors include Syncona.